5,11-dimethyl-5h-indolo(2,3-b)quinoline has been researched along with daunorubicin in 1 studies
| Studies (5,11-dimethyl-5h-indolo(2,3-b)quinoline) | Trials (5,11-dimethyl-5h-indolo(2,3-b)quinoline) | Recent Studies (post-2010) (5,11-dimethyl-5h-indolo(2,3-b)quinoline) | Studies (daunorubicin) | Trials (daunorubicin) | Recent Studies (post-2010) (daunorubicin) |
|---|---|---|---|---|---|
| 11 | 0 | 5 | 8,239 | 886 | 1,310 |
| Protein | Taxonomy | 5,11-dimethyl-5h-indolo(2,3-b)quinoline (IC50) | daunorubicin (IC50) |
|---|---|---|---|
| 72 kDa type IV collagenase | Homo sapiens (human) | 1.9 | |
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | 8 | |
| Histone deacetylase 1 | Homo sapiens (human) | 0.047 | |
| Histone deacetylase 8 | Homo sapiens (human) | 0.22 | |
| Histone deacetylase 6 | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Godlewska, J; Kaczmarek, L; Luniewski, W; Peczynska-Czoch, W; Piskozub, M; Switalska, M; Wietrzyk, J | 1 |
1 other study(ies) available for 5,11-dimethyl-5h-indolo(2,3-b)quinoline and daunorubicin
| Article | Year |
|---|---|
New derivatives of 11-methyl-6-[2-(dimethylamino)ethyl]-6H-indolo[2,3-b]quinoline as cytotoxic DNA topoisomerase II inhibitors.
Topics: Animals; Antineoplastic Agents; BALB 3T3 Cells; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fibroblasts; HL-60 Cells; Humans; Indoles; Jurkat Cells; Male; MCF-7 Cells; Mice; Molecular Structure; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2012 |